These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 9089225)
1. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. Bouthot BA; Murthy BV; Schmid CH; Levey AS; Pereira BJ Transplantation; 1997 Mar; 63(6):849-53. PubMed ID: 9089225 [TBL] [Abstract][Full Text] [Related]
2. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Pereira BJ; Wright TL; Schmid CH; Levey AS Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254 [TBL] [Abstract][Full Text] [Related]
3. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients. Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641 [TBL] [Abstract][Full Text] [Related]
4. Transplantation of kidneys from HCV-positive donors: a safe strategy? Fabrizi F; Bunnapradist S; Lunghi G; Martin P J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406 [TBL] [Abstract][Full Text] [Related]
5. Impact of hepatitis C infection on outcomes after heart transplantation. Fong TL; Hou L; Hutchinson IV; Cicciarelli JC; Cho YW Transplantation; 2009 Nov; 88(9):1137-41. PubMed ID: 19898211 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor. Stepanova M; Sayiner M; de Avila L; Younoszai Z; Racila A; Younossi ZM BMC Gastroenterol; 2016 Nov; 16(1):137. PubMed ID: 27846801 [TBL] [Abstract][Full Text] [Related]
7. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives? Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338 [TBL] [Abstract][Full Text] [Related]
8. Liver transplantation from anti-hepatitis C virus-positive donors: our experience. Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188 [TBL] [Abstract][Full Text] [Related]
10. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978 [TBL] [Abstract][Full Text] [Related]
11. Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients. Miguel M; Sampaio MS; Kuo HT; Poommipanit N; Martin P; Bunnapradist S Transplantation; 2010 Jul; 90(1):61-7. PubMed ID: 20463638 [TBL] [Abstract][Full Text] [Related]
12. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Periera BJ; Wright TL; Schmid CH; Levey AS Transplantation; 1995 Oct; 60(8):799-805. PubMed ID: 7482738 [TBL] [Abstract][Full Text] [Related]
13. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus). Natov SN Transpl Infect Dis; 2002 Sep; 4(3):124-31. PubMed ID: 12421456 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data. Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111 [TBL] [Abstract][Full Text] [Related]
15. GB hepatitis agent in cadaver organ donors and their recipients. Murthy BV; Muerhoff AS; Desai SM; Lund J; Schmid CH; Levey AS; Mushahwar IK; Pereira BJ Transplantation; 1997 Feb; 63(3):346-51. PubMed ID: 9039921 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients. Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359 [TBL] [Abstract][Full Text] [Related]
17. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Pereira BJ; Natov SN; Bouthot BA; Murthy BV; Ruthazer R; Schmid CH; Levey AS Kidney Int; 1998 May; 53(5):1374-81. PubMed ID: 9573555 [TBL] [Abstract][Full Text] [Related]
18. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors. Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517 [TBL] [Abstract][Full Text] [Related]